Abstract
Radiotherapy or radiation therapy is a fundamental part of the multidisciplinary management of breast cancer. It is a treatment that utilizes high-energy X-rays, protons, or other unstable particles, in which hyperproliferative cells, such as cancer cells are affected more and therefore more susceptible to radiotherapy compared to normal cells. When treating early-stage breast cancer, radiotherapy can often be given before, during, or after surgery, in order to shrink tumors or to eradicate cancer cells. Postoperative radiation allows to destroy any cancer cells that may remain after surgery and lowers the risk of recurrence. Radiotherapy can also be used in cases of unresectable or metastatic breast cancers where surgery is no longer a viable option. The modality used, such as external beam therapy, brachytherapy, intraoperative therapy, and the dosage used, varies depending on the treatment plan. The dose of radiation given is split into fractions, usually given daily, over a few days or weeks, depending on the choice of radiotherapy. A combination of chemotherapy or immunotherapy with radiotherapy is recommended for the progressive stages of breast cancer. This chapter dwells on different types of radiotherapy, methods of administration, evolution, benefits, and adverse effects of radiotherapy in breast cancer.
This is a preview of subscription content, log in via an institution to check access.
References
Abdulkareem IH, Zurmi IB (2012) Review of hormonal treatment of breast cancer. Niger J Clin Pract 15(1):9–14. https://doi.org/10.4103/1119-3077.94088
Alkabban FM (2021) Breast cancer. StatPearls Publishing. Retrieved from https://pubmed.ncbi.nlm.nih.gov/29493913/
Anderson KN, Schwab RB, Martinez ME (2014) Reproductive risk factors and breast cancer subtypes: a review of the literature. Breast Cancer Res Treat 144(1):1–10. https://doi.org/10.1007/S10549-014-2852-7
Arps DP, Healy P, Zhao L, Kleer CG, Pang JC (2013) Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast. Breast Cancer Res Treat 138(3):719–726. https://doi.org/10.1007/S10549-013-2493-2
Ashbeck EL, Rosenberg RD, Stauber PM, Key CR (2007) Benign breast biopsy diagnosis and subsequent risk of breast cancer. Cancer Epidemiol Biomark Prevent 16(3):467–472. https://doi.org/10.1158/1055-9965.EPI-06-0394
Banerjee R, Kamrava M (2014) Brachytherapy in the treatment of cervical cancer: a review. Int J Women’s Health 6(1):555. https://doi.org/10.2147/IJWH.S46247
Baskar R, Lee KA, Yeo R, Yeoh KW (2012) Cancer and radiation therapy: current advances and future directions. Int J Med Sci 9(3):193. https://doi.org/10.7150/IJMS.3635
Baskar R, Dai J, Wenlong N, Yeo R, Yeoh KW (2014) Biological response of cancer cells to radiation treatment. Front Mol Biosci 1(NOV). https://doi.org/10.3389/FMOLB.2014.00024
Bilous M (2010) Breast core needle biopsy: issues and controversies. Mod Pathol 23(2):S36–S45. https://doi.org/10.1038/modpathol.2010.34
Buwenge M, Cammelli S, Ammendolia I, Tolento G, Zamagni A, Arcelli A et al (2017) Intensity modulated radiation therapy for breast cancer: current perspectives. Breast Cancer 9:121. https://doi.org/10.2147/BCTT.S113025
Cassidy J, Bissett D, Spence RAJ, Payne M, Morris-Stiff G (2015) Oxford handbook of oncology, 4th edn. Edition by Donald Bissett, pp 261–299. https://doi.org/10.1093/med/9780199689842.001.0001
Chandarana H, Wang H, Tijssen RHN, Das IJ (2018) Emerging role of MRI in radiation therapy. J Magn Resonan Imag 48(6):1468. https://doi.org/10.1002/JMRI.26271
Chowdhary M, Lee A, Gao S, Wang D, Barry PN, Diaz R et al (2019) Is proton therapy a “pro” for breast cancer? A comparison of proton vs. non-proton radiotherapy using the national cancer database. Front Oncol 9(JAN). https://doi.org/10.3389/FONC.2018.00678/PDF
CollaborativeGroup E (1995) Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 333(22):1444–1456. https://doi.org/10.1056/NEJM199511303332202
Commandeur F, Simon A, Mathieu R, Nassef M, Arango JDO, Rolland Y et al (2017) MRI to CT prostate registration for improved targeting in cancer external beam radiotherapy. IEEE J Biomed Health Inf 21(4):1015–1026. https://doi.org/10.1109/JBHI.2016.2581881
Conte P, Gennari A, Guarneri V, Landucci E, Donati S, Salvadori B, Bengala C, Orlandini C (2001) Epirubicin/taxane combinations in breast cancer: experience from several Italian trials. Oncology (Williston Park) 15(5):21–23. Retrieved from https://pubmed.ncbi.nlm.nih.gov/11396360/
Cserni G, Chmielik E, Cserni B, Tot T (2018) The new TNM-based staging of breast cancer. Virchows Archiv 472(5):697–703. https://doi.org/10.1007/S00428-018-2301-9
Czajka ML, Pfeifer C (2021) Breast cancer surgery. Br J Med Pract 13(1):1. https://doi.org/10.1093/med/9780198839248.003.0013
de Cremoux P, Diéras V, Poupon M-F Magdelénat H, Sigal-Zafrani B, Alain Fourquet J-YP (2004) [Tamoxifen and aromatase inhibitors in the treatment of breast cancer in menopausal women: pharmacological and clinical aspects]. Bull Cancer 91(12):917–927. Retrieved from https://pubmed.ncbi.nlm.nih.gov/15634633/
Dray N (2011) Harrison’s hematology and oncology. Yale J Biol Med 84(1):64. Retrieved from /pmc/articles/PMC3064251/
Eisen A, Trudeau M, Shelley W, Messersmith H, Pritchard KI (2008) Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review. Cancer Treat Rev 34(2):157–174. https://doi.org/10.1016/J.CTRV.2007.11.001
Evans A, Trimboli RM, Athanasiou A, Balleyguier C, Baltzer PA, Bick U et al (2018) Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging. Insights into Imaging 9(4):449. https://doi.org/10.1007/S13244-018-0636-Z
Feng Y, Spezia M, Huang S, Yuan C, Zeng Z, Zhang L et al (2018) Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis. Genes Dis 5(2):77–106. https://doi.org/10.1016/J.GENDIS.2018.05.001
Gajdos C, Ian Tartter P, Bleiweiss IJ, Hermann G, De Csepel J, Estabrook A, Rademaker AW (2002) Mammographic appearance of nonpalpable breast cancer reflects pathologic characteristics. Ann Surg 235(2):246. https://doi.org/10.1097/00000658-200202000-00013
Gianfaldoni S, Gianfaldoni R, Wollina U, Lotti J, Tchernev G, Lotti T (2017) An overview on radiotherapy: from its history to its current applications in dermatology. Open Access Macedonian J Med Sci 5(4):521. https://doi.org/10.3889/OAMJMS.2017.122
Goh CW, Wu J, Ding S, Lin C, Chen X, Huang O et al (2019) Invasive ductal carcinoma with coexisting ductal carcinoma in situ (IDC/DCIS) versus pure invasive ductal carcinoma (IDC): a comparison of clinicopathological characteristics, molecular subtypes, and clinical outcomes. J Cancer Res Clin Oncol 145(7):1877–1886. https://doi.org/10.1007/S00432-019-02930-2
Gokhale S (2009) Ultrasound characterization of breast masses. Indian J Radiol Imag 19(3):242. https://doi.org/10.4103/0971-3026.54878
Gupta T, Agarwal J, Jain S, Phurailatpam R, Kannan S, Ghosh-Laskar S et al (2012) Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. Radiother Oncol 104(3):343–348. https://doi.org/10.1016/J.RADONC.2012.07.001
Gurram L, Wadasadawala T, Joshi K, Phurailatpam R, Paul S, Sarin R (2016) Multi-catheter interstitial brachytherapy for partial breast irradiation: an audit of implant quality based on dosimetric evaluation comparing intra-operative versus post-operative placement. J Contemp Brachyther 8(2):116–121. https://doi.org/10.5114/JCB.2016.59195
Hansen EK (2010) Handbook of evidence-based radiation oncology. https://doi.org/10.1007/978-0-387-92988-0
Healy BJ, van der Merwe D, Christaki KE, Meghzifene A (2017) Cobalt-60 machines and medical linear accelerators: competing technologies for external beam radiotherapy. Clin Oncol (Royal College of Radiologists (Great Britain)) 29(2):110–115. https://doi.org/10.1016/J.CLON.2016.11.002
Henricks LM, Schellens JHM, Huitema ADR, Beijnen JH (2015) The use of combinations of monoclonal antibodies in clinical oncology. Cancer Treat Rev 41(10):859–867. https://doi.org/10.1016/J.CTRV.2015.10.008
Huang CS, Wu CY, Chu JS, Lin JH, Hsu SM, Chang KJ (1999) Microcalcifications of non-palpable breast lesions detected by ultrasonography: correlation with mammography and histopathology. Ultrasound Obstetr Gynecol 13(6):431–436. https://doi.org/10.1046/J.1469-0705.1999.13060431.X
Hubenak JR, Zhang Q, Branch CD, Kronowitz SJ (2014) Mechanisms of injury to normal tissue after radiotherapy: a review. Plast Reconstr Surg 133(1):49e. https://doi.org/10.1097/01.PRS.0000440818.23647.0B
Huh HD, Kim S (2020) History of radiation therapy technology. Korean Soc Med Phys 31(3):124–134. https://doi.org/10.14316/PMP.2020.31.3.124
Ingledew PA, Kong T (2021). Side effects. Radiation oncology basics. Retrieved from Learn Oncology website: https://www.learnoncology.ca/modules/radiation-oncology-basics#section-6
Jacobson G, Kaidar-Person O, Haisraely O, Galper S, Rabin T, Dromi Shahadi I et al (2021) Palliative radiation therapy for symptomatic advance breast cancer. Sci Rep 11(1):5282. https://doi.org/10.1038/S41598-021-84872-9
Jaffray DA, Gospodarowicz MK (2015) Radiation therapy for cancer. J Korean Med Assoc 6:142–146. https://doi.org/10.1596/978-1-4648-0349-9_CH14
Krásenská M (2016) [Treatment with aromatase inhibitors in postmenopausal women with breast cancer and the possibility of influencing side effects]. Klinicka Onkologie: Casopis Ceske a Slovenske Onkologicke Spolecnosti 29(Suppl 3):S39–S49. https://doi.org/10.14735/AMKO20163S39
Kumar P, Aggarwal R (2016) An overview of triple-negative breast cancer. Arch Gynecol Obstet 293(2):247–269. https://doi.org/10.1007/S00404-015-3859-Y
Lebaron S, Zeltzer LK, Lebaron C, Scott SE, Zeltzer PM (1988) Chemotherapy side effects in pediatric oncology patients: drugs, age, and sex as risk factors. Med Pediatr Oncol 16(4):263–268. https://doi.org/10.1002/MPO.2950160408
Lee E, McKean-Cowdin R, Ma H, Spicer DV, Van Den Berg D, Bernstein L, Ursin G (2011) Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women. J Clin Oncol 29(33):4373. https://doi.org/10.1200/JCO.2010.33.6446
Loap P, Kirova Y (2020) Fast neutron therapy for breast cancer treatment: an effective technique sinking into oblivion. Int J Particle Ther 7(3):61–64. https://doi.org/10.14338/IJPT-19-00080.1
Loibl S, Gianni L (2017) HER2-positive breast cancer. Lancet (London, England) 389(10087):2415–2429. https://doi.org/10.1016/S0140-6736(16)32417-5
Mendenhall WM (2020) Radiation oncology. combined-modality therapy. Retrieved February 17, 2022, from https://radonc.med.ufl.edu/patient-care/information-for-patients/cancer-treatment-results/combined-modality-therapy/
Menezes GLG, Knuttel FM, Stehouwer BL, Pijnappel RM, Van Den Bosch MAAJ (2014) Magnetic resonance imaging in breast cancer: a literature review and future perspectives. World J Clin Oncol 5(2):61. https://doi.org/10.5306/WJCO.V5.I2.61
Mokhtari RB, Homayouni TS, Baluch N, Morgatskaya E, Kumar S, Das B, Yeger H (2017) Combination therapy in combating cancer. Oncotarget 8(23):38022–38043. https://doi.org/10.18632/ONCOTARGET.16723
Mouridsen HT (2004) Aromatase inhibitors in advanced breast cancer. Semin Oncol 31(6 Suppl 12):3–8. https://doi.org/10.1053/J.SEMINONCOL.2004.09.020
Nahta R, Esteva FJ (2006) HER2 therapy: molecular mechanisms of trastuzumab resistance. Breast Cancer Res 8(6):1–8. https://doi.org/10.1186/BCR1612/TABLES/1
Natale JJ (2015) Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis. Hosp Practice (1995) 43(4):226–234. https://doi.org/10.1080/21548331.2015.1077095
Nixon AJ, Manola J, Gelman R, Bornstein B, Abner A, Hetelekidis S et al (1998) No long-term increase in cardiac-related mortality after breast-conserving surgery and radiation therapy using modern techniques. J Clin Oncol Off J Am Soc Clin Oncol 16(4):1374–1379. https://doi.org/10.1200/JCO.1998.16.4.1374
Ogawa M (1997) [Anticancer drugs and pharmacologic actions]. Retrieved February 17, 2022, from Japanese website: https://pubmed.ncbi.nlm.nih.gov/9155146/
Papademetriou K, Ardavanis A, Kountourakis P (2010) Neoadjuvant therapy for locally advanced breast cancer: Focus on chemotherapy and biological targeted treatments’ armamentarium. J Thoracic Dis 2(3):160. https://doi.org/10.3978/J.ISSN.2072-1439.2010.02.03.8
Peddi PF (2018) Hormone receptor positive breast cancer: state of the art. Curr Opin Obstet Gynecol 30(1):51–54. https://doi.org/10.1097/GCO.0000000000000424
Pereira GC, Traughber M, Muzic RF (2014) The role of imaging in radiation therapy planning: past, present, and future. Biomed Res Int 2014. https://doi.org/10.1155/2014/231090
Popescu CC, Olivotto IA, Beckham WA, Ansbacher W, Zavgorodni S, Shaffer R et al (2010) Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes. Int J Radiat Oncol Biol Phys 76(1):287–295. https://doi.org/10.1016/J.IJROBP.2009.05.038
Qiu JJ, Chang Z, Wu QJ, Yoo S, Horton J, Yin FF (2010) Impact of volumetric modulated arc therapy technique on treatment with partial breast irradiation. Int J Radiat Oncol Biol Phys 78(1):288–296. https://doi.org/10.1016/J.IJROBP.2009.10.036
Raina V, Bhutani M, Bedi R, Sharma A, Deo SVS, Shukla NK et al (2005) Clinical features and prognostic factors of early breast cancer at a major cancer center in North India. Indian J Cancer 42(1):36–41. https://doi.org/10.4103/0019-509X.15099
Ribeiro JT, Macedo LT, Curigliano G, Fumagalli L, Locatelli M, Dalton M et al (2012) Cytotoxic drugs for patients with breast cancer in the era of targeted treatment: back to the future? Ann Oncol 23(3):547–555. https://doi.org/10.1093/ANNONC/MDR382
Russo J, Russo IH (2006) The role of estrogen in the initiation of breast cancer. J Steroid Biochem Mol Biol 102(1–5):89–96. https://doi.org/10.1016/J.JSBMB.2006.09.004
Rutqvist LE, Rose C, Cavallin-Ståhl E (2003) A systematic overview of radiation therapy effects in breast cancer. Acta Oncol (Stockholm, Sweden) 42(5–6):532–545. https://doi.org/10.1080/02841860310014444
Shah C, Vicini F, Shaitelman SF, Hepel J, Keisch M, Arthur D et al (2018) The American Brachytherapy Society consensus statement for accelerated partial-breast irradiation. Brachytherapy 17(1):154–170. https://doi.org/10.1016/J.BRACHY.2017.09.004
Shapiro CL, Recht A (2001) Side effects of adjuvant treatment of breast cancer. N Engl J Med 344(26):1997–2008. https://doi.org/10.1056/NEJM200106283442607
Sharma GN, Dave R, Sanadya J, Sharma P, Sharma KK (2010) Various types and management of breast cancer: an overview. J Adv Pharma Technol Res 1(2):109. Retrieved from /pmc/articles/PMC3255438/
Skowronek J (2017) Current status of brachytherapy in cancer treatment – short overview. J Contemp Brachyther 9(6):581. https://doi.org/10.5114/JCB.2017.72607
Skowronek J, Chicheł A (2014) Brachytherapy in breast cancer: an effective alternative. Przeglad Menopauzalny = Menopause Rev 13(1):48–55. https://doi.org/10.5114/pm.2014.41090
Soerjomataram I, Louwman MWJ, Ribot JG, Roukema JA, Coebergh JWW (2008) An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 107(3):309. https://doi.org/10.1007/S10549-007-9556-1
Sullivan SD, Sarrel PM, Nelson LM (2016) Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause. Fertil Steril 106(7):1588. https://doi.org/10.1016/J.FERTNSTERT.2016.09.046
Sun J, Lee MC (2020) Clinical presentation, diagnosis and prognosis of pregnancy-associated breast cancer. Adv Exp Med Biol 1252:87–93. https://doi.org/10.1007/978-3-030-41596-9_11
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/CAAC.21660
Tai YC, Domchek S, Parmigiani G, Chen S (2007) Breast cancer risk among male BRCA1 and BRCA2 mutation carriers. J Natl Cancer Inst 99(23):1811–1814. https://doi.org/10.1093/JNCI/DJM203
Taylor CW, Kirby AM (2015) Cardiac side-effects from breast cancer radiotherapy. Clin Oncol (Royal College of Radiologists (Great Britain)) 27(11):621–629. https://doi.org/10.1016/J.CLON.2015.06.007
Thorpe CS, Niska JR, Girardo ME, Kosiorek HE, McGee LA, Hartsell WF et al (2019) Proton beam therapy reirradiation for breast cancer: multi-institutional prospective PCG registry analysis. Breast J 25(6):1160–1170. https://doi.org/10.1111/TBJ.13423
Tsimberidou AM (2015) Targeted therapy in cancer. Cancer Chemother Pharmacol 76(6):1113–1132. https://doi.org/10.1007/S00280-015-2861-1
Waddle MR, Chen RC, Arastu NH, Green RL, Jackson M, Qaqish BF et al (2015) Unanticipated hospital admissions during or soon after radiation therapy: incidence and predictive factors. Pract Radiat Oncol 5(3):e245–e253. https://doi.org/10.1016/J.PRRO.2014.08.004
Wang J, Trovati S, Borchard PM, Loo BW, Maxim PG, Fahrig R (2017) Thermal limits on MV x-ray production by bremsstrahlung targets in the context of novel linear accelerators. Med Phys 44(12):6610–6620. https://doi.org/10.1002/MP.12615
Warren LEG, Miller CL, Horick N, Skolny MN, Jammallo LS, Sadek BT et al (2014) The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study. Int J Radiat Oncol Biol Phys 88(3):565–571. https://doi.org/10.1016/J.IJROBP.2013.11.232
White RR, Halperin TJ, Olson JA, Soo MS, Bentley RC, Seigler HF (2001) Impact of core-needle breast biopsy on the surgical management of mammographic abnormalities. Ann Surg 233(6):769. https://doi.org/10.1097/00000658-200106000-00006
Wu M, Burstein DE (2004) Fine needle aspiration. Cancer Investig 22(4):620–628. https://doi.org/10.1081/CNV-200027160
Yersal O, Barutca S (2014) Biological subtypes of breast cancer: prognostic and therapeutic implications. World J Clin Oncol 5(3):412. https://doi.org/10.5306/WJCO.V5.I3.412
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
